טוען...
Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada
INTRODUCTION: This analysis compared the cost-effectiveness of once-daily regimens of mirabegron 50 mg and generic tolterodine ER 4 mg in a hypothetical cohort of previously treated patients with overactive bladder (OAB) in Canada. METHODS: A Markov model was developed to represent different health...
שמור ב:
| הוצא לאור ב: | Can Urol Assoc J |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Canadian Medical Association
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5434500/ https://ncbi.nlm.nih.gov/pubmed/28515812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4114 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|